Will sildenafil cause hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Will Sildenafil Cause Hypotension?

Yes, sildenafil causes hypotension through its vasodilatory properties, resulting in mild and transient decreases in blood pressure, with mean peak reductions of approximately 10/7 mm Hg systolic/diastolic. 1, 2

Mechanism of Hypotensive Effect

  • Sildenafil inhibits phosphodiesterase type 5 (PDE5), which blocks the degradation of cyclic guanosine monophosphate (cGMP), leading to vascular smooth muscle relaxation and subsequent vasodilation. 2

  • The blood pressure reductions are not dose-related and occur without compensatory increases in heart rate. 2

  • These hemodynamic effects are similar in healthy men and those with coronary artery disease or taking antihypertensive medications. 3

Clinical Significance of Blood Pressure Changes

The hypotensive effect is generally mild and well-tolerated in most patients, but certain high-risk populations require extreme caution. 1

Low-Risk Scenarios

  • In clinical trials involving over 13,000 patients, the incidence of hypotension, orthostatic hypotension, and syncope was less than 2%, identical to placebo rates. 2

  • The FDA label confirms that sildenafil causes "mild and transient decreases in blood pressure" that are typically not clinically significant in stable patients. 1

  • When combined with various antihypertensive drug classes (beta-blockers, ACE inhibitors, diuretics, calcium antagonists), sildenafil produces additive but not potentiating blood pressure reductions, making clinically significant hypotension unlikely. 4

High-Risk Scenarios Requiring Caution

The FDA mandates careful consideration before prescribing sildenafil to patients with specific underlying conditions that could be adversely affected by vasodilatory effects. 1

Patients at Increased Risk:

  • Those on antihypertensive therapy 1
  • Resting hypotension (BP less than 90/50 mm Hg) 1
  • Fluid depletion 1, 5
  • Severe left ventricular outflow obstruction 1
  • Autonomic dysfunction 1

Absolute Contraindication: Nitrate Combination

The combination of sildenafil with organic nitrates is absolutely contraindicated due to life-threatening hypotension risk. 1, 5

  • The American College of Cardiology designates nitrate use as a Class III (Harm) contraindication, meaning this combination should never be performed. 5, 6

  • Sildenafil and nitrates synergistically potentiate vasodilation through the NO-cGMP pathway, causing profound and potentially fatal hypotension, myocardial infarction, and death. 7, 6

  • Patients must wait at least 24 hours after taking sildenafil before any nitrate can be safely administered. 5, 6

  • Conversely, patients currently using nitrates cannot take sildenafil until they have been nitrate-free for the appropriate washout period. 6

Drug Interaction Considerations

Alpha-Blockers

  • Coadministration with alpha-blockers may lead to symptomatic hypotension in some individuals. 3

  • Patients should be stable on alpha-blocker therapy before initiating sildenafil, and sildenafil should be started at the lowest dose. 3

  • One case report documented pronounced hypotension (RR 60/45 mm Hg) during orthostatic testing in a patient receiving both sildenafil and tamsulosin, despite these drugs being considered hemodynamically safe. 8

Calcium Channel Blockers

  • In a controlled study with amlodipine, the mean additional reduction in supine blood pressure was 8 mm Hg systolic and 7 mm Hg diastolic. 3

Other Antihypertensives

  • Retrospective analysis showed no increase in adverse events or significant hypotensive episodes when sildenafil was combined with beta-blockers, diuretics, or ACE inhibitors compared to sildenafil alone. 2

Monitoring Recommendations

The FDA requires blood pressure monitoring when co-administering blood pressure lowering drugs with sildenafil. 1

Common Pitfalls to Avoid

  • Do not assume that mild baseline hypotension is safe—the FDA specifically warns against use in patients with BP less than 90/50 mm Hg. 1

  • Do not overlook fluid depletion status, particularly in elderly patients, as this predisposes to profound hypotension. 5, 1

  • Do not prescribe sildenafil to patients taking nitrates under any circumstances, regardless of how well-controlled their other conditions may be. 1, 5

  • Do not forget that the hypotensive effect, while typically mild, can be clinically significant in susceptible individuals even when used as monotherapy. 8

References

Research

Overall cardiovascular profile of sildenafil citrate.

The American journal of cardiology, 1999

Guideline

Contraindications and Precautions for Sildenafil Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Contraindication to Phosphodiesterase Inhibitors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Can sildenafil (phosphodiesterase inhibitor) be taken with isosorbide (nitrate)?
What are the contraindications for Viagra (sildenafil) in patients, particularly older adults, with a history of myocardial infarction, stroke, or life-threatening arrhythmias, and those with impaired renal function or severe hepatic impairment?
Can a person taking trimetazidine (anti-anginal medication) take sildenafil (phosphodiesterase type 5 inhibitor)?
Can a patient take sildenafil (Viagra) with Ranexa (ranolazine)?
What are the risks of combining metoprolol (beta-blocker) and Viagra (sildenafil) in an adult male patient with a history of cardiovascular disease, including hypertension, heart failure, or angina, and erectile dysfunction?
What is the appropriate initial management for a 4-year-old child with primary nocturnal enuresis and no other urinary symptoms?
Is fibroadenoma considered a premalignant (pre‑cancerous) lesion?
What are the epidemiology, risk factors, pathogenesis, clinical presentation, diagnostic work‑up (laboratory tests, imaging, functional studies), differential diagnosis, diagnostic criteria, management, treatment and prognosis of bloodstream infections?
Why is high‑intensity statin recommended after acute coronary syndrome rather than moderate‑intensity statin irrespective of LDL‑cholesterol level?
What is the typical tooth morphology in cleidocranial dysplasia?
What is the recommended management and antibiotic regimen for community‑acquired pneumonia, including severity assessment (CURB‑65 or Pneumonia Severity Index), outpatient versus inpatient treatment, and specific choices for patients with recent antibiotic use, comorbidities, β‑lactam allergy, or risk factors for MRSA or Pseudomonas?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.